Literature DB >> 18797448

Is bowel preparation before colonoscopy a risky business for the kidney?

Yeong-Hau H Lien1.   

Abstract

Acute phosphate nephropathy after bowel preparation with oral sodium phosphate (OSP) for colonoscopy has emerged as an important clinical entity. In 2004, five cases of nephrocalcinosis and irreversible renal failure after bowel preparation with OSP were reported. More recently, several retrospective studies have shown that the incidence of acute kidney injury after OSP use is in the range of 1-4%, similar to the incidence of contrast nephropathy in the general population. The degree of renal failure is not generally as severe as in the first reported cases, but irreversible damage can still occur. Millions of people worldwide undergo screening colonoscopies for colon and rectal cancer after the age of 50, so careful patient selection and monitoring for possible complications is essential when OSP is used. In addition to educating patients about the possibility of renal damage, physicians should routinely watch for considerable weight loss during bowel preparation and correct the fluid deficit as needed. Carrying out a renal function panel, which includes serum phosphorus level, is prudent after colonoscopy. Alternative bowel cleansing agents are needed because calcium phosphate precipitation is inevitable after OSP use even in the normal kidney.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18797448     DOI: 10.1038/ncpneph0939

Source DB:  PubMed          Journal:  Nat Clin Pract Nephrol        ISSN: 1745-8323


  17 in total

1.  Colonoscopy preparation-induced disorders in renal function and electrolytes.

Authors:  Matilda Florentin; George Liamis; Moses S Elisaf
Journal:  World J Gastrointest Pharmacol Ther       Date:  2014-05-06

2.  A population-based case-crossover study of polyethylene glycol use and acute renal failure risk in the elderly.

Authors:  Nam-Kyong Choi; Yoosoo Chang; Sun-Young Jung; Yu-Kyong Choi; Joongyub Lee; Jin-Ho Lee; Ju-Young Kim; Byung-Joo Park
Journal:  World J Gastroenterol       Date:  2011-02-07       Impact factor: 5.742

3.  Intra-individual comparison of magnesium citrate and sodium phosphate for bowel preparation at CT colonography: automated volumetric analysis of residual fluid for quality assessment.

Authors:  P Bannas; J Bakke; A Munoz del Rio; P J Pickhardt
Journal:  Clin Radiol       Date:  2014-09-18       Impact factor: 2.350

Review 4.  Mechanism of action and toxicities of purgatives used for colonoscopy preparation.

Authors:  Margaret Adamcewicz; Dilip Bearelly; Gail Porat; Frank K Friedenberg
Journal:  Expert Opin Drug Metab Toxicol       Date:  2011-01       Impact factor: 4.481

Review 5.  Gastrointestinal disorders and renal failure: exploring the connection.

Authors:  Shayan Shirazian; Jai Radhakrishnan
Journal:  Nat Rev Nephrol       Date:  2010-07-06       Impact factor: 28.314

Review 6.  Antihyperglycemic therapy during colonoscopy preparation: A review and suggestions for practical recommendations.

Authors:  Irit Hochberg; Ori Segol; Rachel Shental; Pnina Shimoni; Roy Eldor
Journal:  United European Gastroenterol J       Date:  2019-04-20       Impact factor: 4.623

7.  Hyperphosphatemia after sodium phosphate laxatives in low risk patients: prospective study.

Authors:  Marcela-Noemi Casais; Guillermo Rosa-Diez; Susana Pérez; Elina-Noemi Mansilla; Susana Bravo; Francisco-Carlos Bonofiglio
Journal:  World J Gastroenterol       Date:  2009-12-21       Impact factor: 5.742

8.  A prospective assessment of renal impairment after preparation for colonoscopy: oral sodium phosphate appears to be safe in well-hydrated subjects with normal renal status.

Authors:  M A Korsten; A M Spungen; A R Rosman; H R Ancha; J B Post; S Shaw; K K Hunt; R Williams; W A Bauman
Journal:  Dig Dis Sci       Date:  2009-10-16       Impact factor: 3.199

9.  Correction of hypocalcemia allows optimal recruitment of FGF-23-dependent phosphaturic mechanisms in acute hyperphosphatemia post-phosphate enema.

Authors:  Carolina Gracia-Iguacel; Emilio Gonzalez-Parra; Laura Rodriguez-Osorio; Ana Belén Sanz; Yolanda Almaden; Concepcion de la Piedra; Jesus Egido; Mariano Rodriguez; Alberto Ortiz
Journal:  J Bone Miner Metab       Date:  2013-05-16       Impact factor: 2.626

10.  Calcium phosphate microcrystals in the renal tubular fluid accelerate chronic kidney disease progression.

Authors:  Kazuhiro Shiizaki; Asako Tsubouchi; Yutaka Miura; Kinya Seo; Takahiro Kuchimaru; Hirosaka Hayashi; Yoshitaka Iwazu; Marina Miura; Batpurev Battulga; Nobuhiko Ohno; Toru Hara; Rina Kunishige; Mamiko Masutani; Keita Negishi; Kazuomi Kario; Kazuhiko Kotani; Toshiyuki Yamada; Daisuke Nagata; Issei Komuro; Hiroshi Itoh; Hiroshi Kurosu; Masayuki Murata; Makoto Kuro-O
Journal:  J Clin Invest       Date:  2021-08-16       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.